Suzuken Co., Ltd. (TYO:9987)
Japan
· Delayed Price · Currency is JPY 5,104.00
+22.00 (0.43%)
May 15, 2025, 3:30 PM JST
Suzuken Revenue
In the fiscal year ending March 31, 2025, Suzuken had annual revenue of 2.40T JPY with 0.56% growth. Suzuken had revenue of 561.28B in the quarter ending March 31, 2025, a decrease of -1.90%.
Revenue
2,399.95B
Revenue Growth
+0.56%
P/S Ratio
0.15
Revenue / Employee
183.40M
Employees
13,086
Market Cap
367.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,399.95B | 13.46B | 0.56% |
| Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
| Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
| Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
| Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |